NCT04340986招募中不适用
Cohort Study of Patients With Primary Hepatocellular Carcinoma or Cholangiocarcinoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,250
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
详细描述
The collection of data from patients with CHC and cholangiocarcinomas who are cancers with poor prognosis is a major challenge to improve patients'care (diagnosis, prognosis); facilitate the search for new therapeutic targets and the follow-up of clinical studies; and develop personalized treatments.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inclusion Criteria :
- •Age ≥ 18 years olds
- •Medical care in Nephrology department since 2015
- •Cholangiocarcinoma:
- •Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease
- •Hepatocellular carcinoma:
- •Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI
- •Hepatocellular histologically documented
排除标准
- •Lack of patient non-opposition
结局指标
主要结局
Overall survival
时间窗: 5 years
Hepatocellular carcinoma and Cholangiocarcinoma : Overall survival is defined as the survival 5 years after the inclusion.
次要结局
- Disease free survival(2 and 5 years)
- Overall survival(5 years)
- Progression time under chemotherapy(Time of progression under chemotherapy up to 5 years)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Primary Hepatobiliary Cancer Cohort of Central ChinaBiliary Tract NeoplasmsHepatocellular CarcinomaNCT05520801Tongji Hospital2,000
终止
不适用
International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid BiopsyEarly Stage Liver CancerLiver CirrhosisLiver CancerHepatocellular CarcinomaNCT05342350Johns Hopkins University360
Unknown
不适用
Observational Study on Patients With Hepatocellular Carcinoma (HCC)Hepatocellular CarcinomaNCT04021056Nanfang Hospital, Southern Medical University3,000
终止
3 期
HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular CancerHepatocellular CarcinomaNCT01387932Merit Medical Systems, Inc.235
招募中
不适用
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabAdvanced Hepatocellular CarcinomaNCT05173298CHA University100